Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines

TerminatedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Synflorix™

Intramuscular administration of three doses/two doses/one dose of primary vaccination/the booster dose/ catch-up dose(s) of Synflorix according to local prescribing information.

Trial Locations (2)

1113

GSK Investigational Site, Quezon City

Unknown

GSK Investigational Site, Santa Mesa, Manila

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY